当前位置：药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目更新到2026-3-31)
药品名称： 商品名称： 药品NDC： 报告期内： -格式:2020-5-3
NDC包装id： 市场分类： 活性成分： 持证企业：
 美国NDC复合药物数据库文件4843条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
Benzocaine Lidocaine Tetracaine 20/6/4
HUMAN COMPOUNDED DRUG
26436-5200
Hybrid Pharma
2024-2
BENZOCAINE; TETRACAINE; LIDOCAINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
200 mg/1 g; 40 mg/1 g; 60 mg/1 g
26436-5200-6
TESTOSTERONE 3mg
HUMAN COMPOUNDED DRUG
26436-5356
Hybrid Pharma
2024-2
TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
3 mg/1 g
26436-5356-1
Phenol
HUMAN COMPOUNDED DRUG
26436-5580
Hybrid Pharma
2024-2
PHENOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg/1 mL
26436-5580-1
Dehydroepiandosterone
HUMAN COMPOUNDED DRUG
26436-5627
Hybrid Pharma
2024-2
PRASTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
25 mg
26436-5627-1
NICOTINAMIDE ADENINE DINUCLEOTIDE 50mg
HUMAN COMPOUNDED DRUG
26436-5558
Hybrid Pharma
2024-2
NADIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg/1 mL
26436-5558-5
NICOTINAMIDE ADENINE DINUCLEOTIDE 50mg
HUMAN COMPOUNDED DRUG
26436-5558
Hybrid Pharma
2024-2
NADIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg/1 mL
26436-5558-0
Fentanyl and Bupivacaine
HUMAN COMPOUNDED DRUG
71266-9227
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
FENTANYL CITRATE; BUPIVACAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 ug/1 mL; 1.25 mg/1 mL
71266-9227-1
Phenylephrine HCl
HUMAN COMPOUNDED DRUG
71266-5250
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg/250 mL
71266-5250-1
Fentanyl and Bupivacaine
HUMAN COMPOUNDED DRUG
71266-9225
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
FENTANYL CITRATE; BUPIVACAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 ug/1 mL; .625 mg/1 mL
71266-9225-1
Phenylephrine HCl
HUMAN COMPOUNDED DRUG
71266-5170
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
200 mg/250 mL
71266-5170-1
Hydromorphone HCl
HUMAN COMPOUNDED DRUG
71266-9115
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
HYDROMORPHONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
71266-9115-1
Midazolam
HUMAN COMPOUNDED DRUG
71266-5030
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
MIDAZOLAM
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
71266-5030-1
Dexamethasone Sodium Phosphate
HUMAN COMPOUNDED DRUG
71266-1041
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
DEXAMETHASONE SODIUM PHOSPHATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 mL
71266-1041-2
Ephedrine
HUMAN COMPOUNDED DRUG
71266-9027
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
EPHEDRINE SULFATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 mg/1 mL
71266-9027-1
Fentanyl and Ropivacaine
HUMAN COMPOUNDED DRUG
71266-9235
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
FENTANYL CITRATE; ROPIVACAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 ug/1 mL; 1.5 mg/1 mL
71266-9235-1
Fentanyl and Bupivacaine
HUMAN COMPOUNDED DRUG
71266-9228
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
FENTANYL CITRATE; BUPIVACAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 ug/1 mL; 1.25 mg/1 mL
71266-9228-1
Lidocaine HCl 2%
HUMAN COMPOUNDED DRUG
71266-9091
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
LIDOCAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
71266-9091-1
Dextrose
HUMAN COMPOUNDED DRUG
71266-0712
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
DEXTROSE MONOHYDRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
700 mg/1 mL
71266-0712-1
Semaglutide
HUMAN COMPOUNDED DRUG
71266-6110
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
SEMAGLUTIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2.5 mg/1 mL
71266-6110-2
011727 BENZOYLPEROXIDE10%/SPIRONOCLATONE4%andCLINDAMYCIN2%/NIACINAMIDE4%/TRETINOIN0.05%
HUMAN COMPOUNDED DRUG
72934-1440
SKNV
2024-2
TRETINOIN; BENZOYL PEROXIDE; NIACINAMIDE; CLINDAMYCIN PHOSPHATE; SPIRONOLACTONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.05 g/100 g; 10 g/100 g; 4 g/100 g; 2 g/100 g; 4 g/100 g
72934-1440-1
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3